Holen Sie sich die Stockscreener-App
1.30
5.11%
-0.07
Handel nachbörslich:
1.28
-0.02
-1.54%
Schlusskurs vom Vortag:
$1.37
Offen:
$1.35
24-Stunden-Volumen:
63,986
Relative Volume:
0.57
Marktkapitalisierung:
$29.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.39M
KGV:
-0.4502
EPS:
-2.8877
Netto-Cashflow:
$-56.24M
1W Leistung:
-10.96%
1M Leistung:
+5.69%
6M Leistung:
-19.00%
1J Leistung:
-55.33%
1-Tages-Spanne:
$1.2801
$1.36
1-Wochen-Bereich:
$1.2801
$1.47
52-Wochen-Spanne:
$1.00
$3.75
Boundless Bio Inc Stock (BOLD) Company Profile
Firmenname
Boundless Bio Inc
Sektor
Branche
Telefon
(858) 766-9912
Adresse
10955 ALEXANDRIA WAY, SAN DIEGO
Vergleichen Sie BOLD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.30 | 30.67M | 0 | -64.39M | -56.24M | -2.8877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-05-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-04-22 | Eingeleitet | Guggenheim | Buy |
| 2024-04-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-22 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Boundless Bio Inc Aktie (BOLD) Neueste Nachrichten
Market reaction to Boundless Bio Inc.’s recent news2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Is this a good reentry point in Boundless Bio Inc.2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Will Boundless Bio Inc. stock benefit from infrastructure spendingJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Volatility clustering patterns for Boundless Bio Inc.2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com
What analyst consensus says on Boundless Bio Inc. stock2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
Can Boundless Bio Inc. stock sustain institutional interest2025 Year in Review & Stock Timing and Entry Methods - newser.com
How to build a custom watchlist for Boundless Bio Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Can Boundless Bio Inc. stock outperform in 2025 bull marketJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Is Boundless Bio Inc. stock positioned for digital transformationWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
Boundless Bio Inc. stock trend outlook and recovery pathJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Is Boundless Bio Inc. a candidate for recovery playWeekly Stock Summary & Safe Entry Zone Identification - newser.com
How Boundless Bio Inc. stock valuations compare to rivals2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
How to monitor Boundless Bio Inc. with trend dashboardsJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
Is Boundless Bio Inc. stock a buy for dividend growthM&A Rumor & Fast Exit Strategy with Risk Control - newser.com
Applying chart zones and confluence areas to Boundless Bio Inc.Risk Management & Technical Pattern Alert System - newser.com
Will Boundless Bio Inc. bounce back from current supportJuly 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
Detecting support and resistance levels for Boundless Bio Inc.Market Activity Recap & Weekly Momentum Picks - newser.com
Will Boundless Bio Inc. stock go up soonTake Profit & Low Risk Entry Point Tips - newser.com
Finanzdaten der Boundless Bio Inc-Aktie (BOLD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):